Torthaí cuardaigh - Lakshmi Nayak

Beachtaigh na torthaí
  1. 1
    Introduction of novel agents in the treatment of primary CNS lymphoma

    Introduction of novel agents in the treatment of primary CNS lymphoma de réir Christian Grommes, Lakshmi Nayak, Han W. Tun, Tracy T. Batchelor

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Glioblastoma in the elderly

    Glioblastoma in the elderly de réir Fábio M. Iwamoto, Anna R. Cooper, Anne S. Reiner, Lakshmi Nayak, Lauren E. Abrey

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Prognosis and patterns of care in elderly patients with glioma

    Prognosis and patterns of care in elderly patients with glioma de réir Fábio M. Iwamoto, Anne S. Reiner, Lakshmi Nayak, Katherine S. Panageas, Elena B. Elkin, Lauren E. Abrey

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Late relapse in primary central nervous system lymphoma: clonal persistence

    Late relapse in primary central nervous system lymphoma: clonal persistence de réir Lakshmi Nayak, Cyrus V. Hedvat, Marc K. Rosenblum, Lauren E. Abrey, Lisa M. DeAngelis

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Medical management of brain tumors and the sequelae of treatment

    Medical management of brain tumors and the sequelae of treatment de réir D. Schiff, E. Q. Lee, Lakshmi Nayak, Andrew D. Norden, David A. Reardon, P. Y. Wen

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma

    Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma de réir Matthias Holdhoff, Maciej M. Mrugała, Christian Grommes, Thomas Kaley, Lode J. Swinnen, Carlos A. Perez-Heydrich, Lakshmi Nayak

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    High‐dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission

    High‐dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first com... de réir Zachariah DeFilipp, Shuli Li, Areej El‐Jawahri, Philippe Armand, Lakshmi Nayak, Nancy Wang, Tracy T. Batchelor, Yi‐Bin Chen

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors

    Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors de réir Lakshmi Nayak, Martin Fleisher, Rita Gonzalez-Espinoza, Oscar Lin, Katherine S. Panageas, Anne S. Reiner, Chhui-Mei Liu, Lisa M. DeAngelis, Antonio Omuro

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

    PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma de réir Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce, Srinivasan Mukundan, Margaretha G.M. Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

    Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma de réir Lakshmi Nayak, Lauren E. Abrey, Jan Drappatz, Mark R. Gilbert, David A. Reardon, Patrick Y. Wen, Michael D. Prados, Lisa M. DeAngelis, Antonio Omuro

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Primary central nervous system lymphoma

    Primary central nervous system lymphoma de réir Andrés J.M. Ferreri, Teresa Calimeri, Kate Cwynarski, Jörg Dietrich, Christian Grommes, Khê Hoang‐Xuan, Leland Hu, Gerald Illerhaus, Lakshmi Nayak, Maurilio Ponzoni, Tracy T. Batchelor

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative

    Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative de réir Linda Dirven, Terri S. Armstrong, Jaishri O. Blakeley, Paul D. Brown, Robin Grant, Rakesh Jalali, Heather Leeper, Tito R. Mendoza, Lakshmi Nayak, Jaap C. Reijneveld, Émilie Le Rhun, Tobias Walbert, Michael Weller, Patrick Y. Wen, Martin Klein

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

    The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab de réir Raymond Y. Huang, Rifaquat Rahman, Karla V. Ballman, Sara J. Felten, S. Keith Anderson, Benjamin M. Ellingson, Lakshmi Nayak, Eudocia Q. Lee, Lauren E. Abrey, Evanthia Galanis, David A. Reardon, Whitney B. Pope, Timothy F. Cloughesy, Patrick Y. Wen

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

    Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma de réir Matthew J. Frigault, Jörg Dietrich, Maria Martinez‐Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Extent of resection and overall survival for patients with atypical and malignant meningioma

    Extent of resection and overall survival for patients with atypical and malignant meningioma de réir Ayal A. Aizer, Wenya Linda Bi, Manjinder Singh Kandola, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, Rameen Beroukhim, David A. Reardon, Patrick Y. Wen, Ossama Al‐Mefty, Nils D. Arvold, Ian F. Dunn, Brian M. Alexander

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study

    Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study de réir Jorge J. Castillo, Shirley D’Sa, Michael P. Lunn, Monique C. Minnema, Alessandra Tedeschi, Frederick Lansigan, M. Lia Palomba, Marzia Varettoni, Ramón García‐Sánz, Lakshmi Nayak, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Irene M. Ghobrial, Steven P. Treon

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

    Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study de réir Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

    Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101 de réir Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina D. Wagner‐Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study de réir Nicholas Butowski, Howard Colman, John de Groot, Antonio Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason T. Huse, Joanna J. Phillips, Brian L. West, K. B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael D. Prados

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

    Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older de réir Jacob G. Scott, Luc Bauchet, Tyler J. Fraum, Lakshmi Nayak, Anna R. Cooper, Samuel T. Chao, John H. Suh, Michael A. Vogelbaum, David M. Peereboom, Sonia Zouaoui, Hélène Mathieu‐Daudé, Pascale Fabbro‐Peray, Valérie Rigau, Luc Taillandier, Lauren E. Abrey, Lisa M. DeAngelis, Joanna H. Shih, Fábio M. Iwamoto

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: